Agios Pharmaceuticals reported $0 in Operating Profit for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -19M 33M
Alexion Pharmaceuticals ALXN:US $ -1370.2M 2065.7M
Alnylam Pharmaceuticals ALNY:US $ -225.2M 26.34M
Amgen AMGN:US $ 2323M 32M
AstraZeneca AZN:LN 1.17B 113M
Bayer BAYN:GR -1078400000 1.33B
Biogen BIIB:US $ 1086.4M 888.1M
Biomarin Pharmaceutical BMRN:US $ -40.94M 145.91M
Bluebird Bio BLUE:US $ -25.94M 177.48M
Bristol Myers Squibb BMY:US $ 942M 61M
Daiichi Sankyo 4568:JP Y 34122M 50903M
Eli Lilly And LLY:US $ 1196.8M 394M
Exelixis EXEL:US $ 75M 23M
Gilead Sciences GILD:US $ -2983M 5385M
GlaxoSmithKline GSK:LN 285M 83.6M
Immunogen IMGN:US $ -16.73M 1.64M
JAZZ PHA JAZZ:US $ 195.61M 1.98M
Merk MRK:US $ 3129M 780M
Novartis NOVN:VX 2.35B 392M
Novartis NVS:US $ 2412M 60M
Pfizer PFE:US $ 3441M 1147M
Puma Biotechnology PBYI:US $ 7M 22M
Regeneron Pharmaceuticals REGN:US $ 656.4M 43.7M
Sarepta Therapeutics SRPT:US $ -139M 20M
Seattle Genetics SGEN:US $ 638.19M 732.15M
Vertex Pharmaceuticals VRTX:US $ 718.03M 2.19M
YTE INCY:US $ 230.77M 894.78M